144 related articles for article (PubMed ID: 27097947)
1. Expression level of microRNA-195 in the serum of patients with gastric cancer and its relationship with the clinicopathological staging of the cancer.
Shen YH; Xie ZB; Yue AM; Wei QD; Zhao HF; Yin HD; Mai W; Zhong XG; Huang SR
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1283-7. PubMed ID: 27097947
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis.
Xin SY; Feng XS; Zhou LQ; Sun JJ; Gao XL; Yao GL
World J Gastroenterol; 2014 Jun; 20(22):6906-11. PubMed ID: 24944481
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of low miR-144 expression in gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 20(4):547-552. PubMed ID: 28800316
[TBL] [Abstract][Full Text] [Related]
6. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
Cui Z; Zheng X; Kong D
World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of serum and tissue miR-107 in human gastric cancer: Correlation with tumor hypoxia.
Ayremlou N; Mozdarani H; Mowla SJ; Delavari A
Cancer Biomark; 2015; 15(6):851-60. PubMed ID: 26406411
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of miR-92a in patients with gastric cancer.
Ren C; Wang W; Han C; Chen H; Fu D; Luo Y; Yao H; Wang D; Ma L; Zhou L; Han D; Shen M
Tumour Biol; 2016 Jul; 37(7):9483-91. PubMed ID: 26790436
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
Liu K; Li G; Fan C; Diao Y; Wu B; Li J
J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
[TBL] [Abstract][Full Text] [Related]
10. Correlation between microRNA-421 expression level and prognosis of gastric cancer.
Liu H; Gao Y; Song D; Liu T; Feng Y
Int J Clin Exp Pathol; 2015; 8(11):15128-32. PubMed ID: 26823855
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Expression Levels of Micro Ribonucleic Ccid-10b (miR-10b) and Micro Ribonucleic Acid-181b (miR-181b) with Gastric Cancer and Its Diagnostic Significance.
Gao Y; Xu Z; Yuan F; Li M
Med Sci Monit; 2018 Nov; 24():7988-7995. PubMed ID: 30403658
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Zhang HP; Sun FB; Li SJ
Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.
Su ZX; Zhao J; Rong ZH; Wu YG; Geng WM; Qin CK
Tumour Biol; 2014 Dec; 35(12):12119-25. PubMed ID: 25416437
[TBL] [Abstract][Full Text] [Related]
16. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer.
ZiaSarabi P; Sorayayi S; Hesari A; Ghasemi F
J Cell Biochem; 2019 Aug; 120(8):12376-12381. PubMed ID: 30861177
[TBL] [Abstract][Full Text] [Related]
18. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
20. Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human.
Parvaee P; Sarmadian H; Khansarinejad B; Amini M; Mondanizadeh M
Asian Pac J Cancer Prev; 2019 May; 20(5):1421-1426. PubMed ID: 31127902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
